2.5/1000 4222 (Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg)

Generic Name: metformin/saxagliptin

Pill imprint 2.5/1000 4222 has been identified as Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg.

Kombiglyze XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 2.5/1000 4222

Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg 2.5/1000 4222
Kombiglyze XR metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg 2.5/1000 4222
Kombiglyze XR
Generic Name:
metformin/saxagliptin
Imprint:
2.5/1000
4222
Strength:
metformin hydrochloride extended-release 1000 mg / saxagliptin 2.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-4222
Inactive Ingredients:
carboxymethylcellulose sodium
hypromellose 2208 (15000 mPa.s)
magnesium stearate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)